AdAPT-001

· EpicentRx, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AdAPT-001, covering 2024-10-26 to 2024-10-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors [Phase 2]